Cargando…

Novel mechanism of JNK pathway activation by adenoviral E1A

The adenoviral oncoprotein E1A influences cellular regulation by interacting with a number of cellular proteins. In collaboration with complementary oncogenes, E1A fully transforms primary cells. As part of this action, E1A inhibits transcription of c-Jun:Fos target genes while promoting that of c-J...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romanov, Vasily S., Brichkina, Anna I., Morrison, Helen, Pospelova, Tatiana V., Pospelov, Valery A., Herrlich, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039154/ https://www.ncbi.nlm.nih.gov/pubmed/24742962

Ejemplares similares

Latest progress in tyrosine kinase inhibitors
por: Pospelova, Tatiana V., et al.
Publicado: (2014)

Targeted elimination of senescent Ras-transformed cells by suppression of MEK/ERK pathway
por: Kochetkova, Elena Y., et al.
Publicado: (2017)

Overexpression of Adenoviral E1A Sensitizes E1A+Ras-Transformed Cells to the Action of Histone Deacetylase Inhibitors
por: Igotti, M. V., et al.
Publicado: (2018)

mTOR kinase inhibitor pp242 causes mitophagy terminated by apoptotic cell death in E1A-Ras transformed cells
por: Gordeev, Serguei A., et al.
Publicado: (2015)

Sustained activation of DNA damage response in irradiated apoptosis-resistant cells induces reversible senescence associated with mTOR downregulation and expression of stem cell markers
por: Chitikova, Zhanna V, et al.
Publicado: (2014)

A novel role for mitochondrial fission in macrophages: trained innate immunity induced by beta-glucan
por: Brichkina, Anna, et al.
Publicado: (2023)

Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors
por: Abbink, Peter, et al.
Publicado: (2018)

Pathogenesis and management of adenoviral keratoconjunctivitis
por: Chigbu, DeGaulle I, et al.
Publicado: (2018)

Checkpoints in Adenoviral Production: Cross-Contamination and E1A
por: Haeussler, Dagmar J., et al.
Publicado: (2011)

Expression of adenoviral E1A throws the PIDD switch
por: Radke, Jay R, et al.
Publicado: (2017)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022)

Adenoviral Producer Cells
por: Kovesdi, Imre, et al.
Publicado: (2010)

Targeted adenoviral vectors
por: Vigne, E, et al.
Publicado: (2001)

Xenogenic Adenoviral Vectors
por: Mittal, Suresh K., et al.
Publicado: (2016)

Xenogenic Adenoviral Vectors
por: Both, Gerald W.
Publicado: (2002)

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
por: Padron-Regalado, Eriko, et al.
Publicado: (2022)

Integrin-Dependent Activation of the JNK Signaling Pathway by Mechanical Stress
por: Pereira, Andrea Maria, et al.
Publicado: (2011)

Management of Adenoviral Keratoconjunctivitis: Challenges and Solutions
por: Labib, Bisant A, et al.
Publicado: (2020)

Suppression of mTORC1 activity in senescent Ras-transformed cells neither restores autophagy nor abrogates apoptotic death caused by inhibition of MEK/ERK kinases
por: Kochetkova, Elena Y., et al.
Publicado: (2018)

Discrimination of Kawasaki disease with concomitant adenoviral detection differentiating from isolated adenoviral infection
por: Kim, Jong Han, et al.
Publicado: (2018)

Adenoviral oncoprotein E1B55K mediates colocalization of SSBP2 and PML in response to stress
por: Fleisig, Helen B, et al.
Publicado: (2010)

Novel adenoviral serotype 5 based immunotherapeutic induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
por: Morse, Michael, et al.
Publicado: (2013)

JNK Pathway in CNS Pathologies
por: de los Reyes Corrales, Teresa, et al.
Publicado: (2021)

ADENOVIRAL VECTORS FOR PROTEIN EXPRESSION
por: Von Seggern, Dan J., et al.
Publicado: (1999)

Construction and application of adenoviral vectors
por: Zhang, Hongbo, et al.
Publicado: (2023)

Sprouty is a cytoplasmic target of adenoviral E1A oncoproteins to regulate the receptor tyrosine kinase signalling pathway
por: Zaremba, Angelika, et al.
Publicado: (2011)

Adenoviral E1A Exploits Flexibility and Disorder to Target Cellular Proteins
por: Murrali, Maria Grazia, et al.
Publicado: (2020)

Cancer suppression by systemic inactivation of p38MAPK
por: Brichkina, Anna, et al.
Publicado: (2017)

Pontin/Tip49 acts as a novel regulator of JNK pathway
por: Wang, Xingjun, et al.
Publicado: (2018)

A novel immunocompetent murine model for replicating oncolytic adenoviral therapy
por: Zhang, L, et al.
Publicado: (2015)

The E1a Adenoviral Gene Upregulates the Yamanaka Factors to Induce Partial Cellular Reprogramming
por: Mendoza, Gracia, et al.
Publicado: (2023)

Evaluation of signal transduction pathways after transient cutaneous adenoviral gene delivery
por: Steinstraesser, Lars, et al.
Publicado: (2011)

Immunogenicity and Cross-Reactivity of Rhesus Adenoviral Vectors
por: Iampietro, M. Justin, et al.
Publicado: (2018)

Fulminant Adenoviral-Induced Hepatitis in Immunosuppressed Patients
por: Kager, Juliane, et al.
Publicado: (2022)

The JNK Signaling Pathway in Renal Fibrosis
por: Grynberg, Keren, et al.
Publicado: (2017)

Role of the JNK Pathway in Bladder Cancer
por: Lee, Eun Hye, et al.
Publicado: (2022)

Adenoviral Targeting of Gene Expression to Tumors
por: Hogg, Richard T., et al.
Publicado: (2010)

Factors influencing adenoviral gene transfer
por: Huizinga, TWJ, et al.
Publicado: (2001)

Analysis of adenoviral attachment to human platelets
por: Shimony, Nilly, et al.
Publicado: (2009)

Adenoviral Vectors for Hemophilia Gene Therapy
por: Brunetti-Pierri, N, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_q129m2hhacq8jsi68jqtsncdue